In This Section

Program

Please note that this meeting will take place as an in-person event in Boston, Massachusetts and will not live-stream content for virtual participation. The meeting content will be recorded and made available as an on-demand program after the conference.

All presentations are scheduled to be live, in-person presentations at the date and time specified below unless noted otherwise. Program in progress.

*-Short talk from proffered abstract

[R] – Remote Presentation

Tuesday, July 21

Wednesday, July 22

Thursday, July 23

Friday, July 24

Tuesday, July 21

REGISTRATION

12-9 p.m. | Grand Ballroom Prefunction

Educational Sessions 1-2

2:30-5:30 p.m.

Educational Session 1: To be ANnounced

Constitution Ballroom A

Educational Session 2: To be ANnounced

Constitution Ballroom B

Welcome and Opening Keynote Lectures

6-8 p.m. | Grand Ballroom

Opening Reception

8:15-10 p.m. | Back Bay Ballroom

Wednesday, July 22

Networking Breakfast

7-8 a.m. | Independence Ballroom West

Fireside Chat

8-8:45 a.m. | Grand Ballroom

  • 8:05 a.m. | Fireside Chat
    Richard Pazdur

Break

  • 8:45-9 a.m. | Grand Ballroom Prefunction

Plenary Sessions 1-2

9-11 a.m.

Plenary Session 1: Drug Discovery – Pharma vs Biotech vs Academia

Grand Ballroom

Plenary Session 2: Diagnostics

Constitution Ballroom A

Break

11-11:20 a.m. | Grand Ballroom Prefunction

Drugging the Undruggable Sessions 1-3

11:20 am-12:50 p.m.

Drugging the Undruggable Session 1: Epigenetics

Grand Ballroom
Session Chair: Johnathan R. Whetstine, Fox Chase Cancer Center, Philadelphia, Pennsylvania

Drugging the Undruggable Session 2: Transcription Factors

Constitution Ballroom A
Session Chair: Angela N. Koehler, Koch Institute for Integrative Cancer Research at MIT, Cambridge, Massachusetts

Drugging the Undruggable Session 3: Synthetic Lethality Beyond DDR

Constitution Ballroom B
Session Chair: Timothy A. Yap, The University of Texas MD Anderson Cancer Center, Houston, Texas

Lunch on Own

12:50-3 p.m.

Challenges in Drug Discovery Sessions 1-3

3:15-5 p.m.

Challenges in Drug Discovery Session 1: Biology

Grand Ballroom
Session Chair: Paul Workman, The Institute of Cancer Research, London, United Kingdom

Challenges in Drug Discovery Session 2: Chemistry

Constitution Ballroom A
Session Chair: Kevan Shokat, University of California, San Francisco, California

Challenges in Drug Discovery Session 3: Clinical

Constitution Ballroom B
Session Chair: Matthew D. Hellmann, AstraZeneca, Gaithersburg, Maryland

Poster Session A / Reception

5:15-7:45 p.m. | Back Bay Ballroom

Evening off / Dinner on own

7:45 p.m.

Thursday, July 23

Networking Breakfast

7-8 am | Independence Ballroom West

Keynote Lecture

8-9 am | Grand Ballroom

  • 8:05 a.m. | Keynote Lecture
    William R. Sellers, Broad Institute of MIT and Harvard, Cambridge, Massachusetts
  • 8:45 a.m. | Q&A   

Break

9-9:15 a.m. | Grand Ballroom Prefunction

Plenary Sessions 3-4

9:15-11:15 a.m.

Plenary Session 3: AI in Oncology: Facts and Hopes

Grand Ballroom
Session Chair: Sarah Skerratt, Chief Research Officer, Isomorphic Labs, London, United Kingdom

Plenary Session 4: From RAS Inhibitors to RAS Degraders

Constitution Ballroom A
Session Chair: Rona Yaeger, Memorial Sloan Kettering Cancer Center, New York, New York

Break

11:15-11:30 a.m.

Concurrent Roundtables 1-2

11:30 a.m.-12:30 p.m.

Roundtable 1: Policy

Constitution Ballroom A

Roundtable 2: Accelerating Investigator-Initiated Clinical Trials with Team Science

Constitution Ballroom B

Lunch on Own

12:30-2:45 p.m.

Start-Up Shark Tank

3-4:30 p.m.

Break

4:30-4:45 p.m. | Grand Ballroom Prefunction

Drugging the Surfacesome Sessions 1-3

4:45-6:15 p.m.

Drugging the Surfacesome 1: Drug conjugates for solid tumors – Choosing the Right Modality for the Right Target

Grand Ballroom

Drugging the Surfacesome 2: Multispecifics

Constitution Ballroom A
Session Chair: Daniel S. Chen, Synthetic Design Lab, San Carlos, California

Drugging the Surfacesome 3: Radionucleotides

Constitution Ballroom B
Session Chair: H. Charles Manning, The University of Texas MD Anderson Cancer Center, Houston, Texas

Poster Session B / Reception

6:15-8:45 p.m. | Back Bay Ballroom

Evening off / Dinner on own

8:45 p.m.

Friday, July 24

Networking Breakfast

7-8 a.m. | Independence Ballroom West

Keynote Lecture

8-9 a.m. | Grand Ballroom

Break

9-9:15 a.m. | Grand Ballroom Prefunction

Start-Up Shark Tank

9:15-10:45 a.m.

Break

10:45-11 a.m. | Grand Ballroom Prefunction

Plenary Sessions 5-6

11 a.m-1 p.m.

Plenary Session 5: Degraders in the Era of Precision Oncology

Grand Ballroom
Session Chair: Danette Daniels, Foghorn Therapeutics, Cambridge, Massachusetts

Plenary Session 6: Super CARs – Future of CAR-T Cell Therapy

Constitution Ballroom A
Session Chair: Saar I. Gill, University of Pennsylvania, Philadelphia, Pennsylvania

Closing Comments and Departure

1 p.m.